Aspira Women’s Health Gears Up for Key Investment Conference
Upcoming Presentation at Prominent Investment Event
AUSTIN, Texas — Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), renowned for its advancements in women's health diagnostics, is excited to announce that its CEO, Nicole Sandford, will be addressing attendees at the H.C. Wainwright 26th Annual Global Investment Conference. This noteworthy event is scheduled for September 9-11, 2024, at a prestigious venue in New York.
Details of the Announcement
Aspira’s presentation will be made accessible on demand starting September 9 at 7:00 am ET for all registered participants. Company executives will also hold one-on-one meetings on September 10 and 11, providing a valuable opportunity for investors to engage directly with leadership. Those interested in such interactions are encouraged to connect with their representatives at H.C. Wainwright.
Presentation Accessibility and Future Updates
Following the live session, a replay of the presentation will be available on Aspira's website under the Investors section, allowing those unable to attend live to catch up on key insights shared during the conference.
About Aspira Women’s Health Inc.
Aspira Women’s Health Inc. is unwavering in its commitment to revolutionizing women's health through innovative, non-invasive diagnostic tools powered by artificial intelligence. The company focuses on developing tests that assist healthcare professionals in diagnosing gynecologic diseases effectively and accurately.
Innovative Testing Solutions
The thought-provoking OvaSuite includes OvaWatch and Ova1Plus, representing a comprehensive suite of blood tests aimed at the detection of ovarian cancer. With over 1.2 million women diagnosed with adnexal masses annually in the U.S., these tests play a critical role. OvaWatch boasts an impressive negative predictive value of 99%, serving as a vital assessment tool for women considered to be at risk of ovarian cancer.
Future Directions in Diagnostics
Looking ahead, Aspira is expanding its test pipeline with the ambitious goal of addressing non-invasive diagnostic needs for conditions like endometriosis, affecting millions worldwide. The OvaMDx risk assessment is designed to enhance the sensitivity and accuracy of existing tests by incorporating a mix of microRNA and protein biomarkers with patient information. Additionally, the EndoCheck test aims to revolutionize endometriosis diagnosis through non-invasive methodologies.
Investor Relations Contact Information
Contact:
Nicole Sandford
Chief Executive Officer
Investors@aspirawh.com
Frequently Asked Questions
What is the H.C. Wainwright Conference?
This conference is a significant platform for companies to present their financial and operational information to potential investors and industry stakeholders.
Who is presenting for Aspira Women’s Health?
The CEO, Nicole Sandford, will represent Aspira at the conference, sharing insights about the company’s innovative diagnostic tools.
When can attendees access the presentation?
The on-demand presentation will be available starting September 9 at 7:00 am ET for registered participants.
What products does Aspira offer?
Aspira offers AI-powered tests like OvaWatch and Ova1Plus aimed at diagnosing ovarian cancer, as part of their innovative OvaSuite.
How does Aspira support women's health?
Aspira focuses on developing non-invasive diagnostic solutions to improve the diagnosis and treatment of gynecologic diseases, thus enhancing women's health outcomes.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.